Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma

NCT07241546 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: ARO-RAGE
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals